Descriptive characteristics of continuous oximetry measurement in moderate to severe covid-19 patients

被引:0
|
作者
Jonathan A. Sobel
Jeremy Levy
Ronit Almog
Anat Reiner-Benaim
Asaf Miller
Danny Eytan
Joachim A. Behar
机构
[1] Israel Institute of Technology,Faculty of Biomedical Engineering, Technion
[2] Israel Institute of Technology,Faculty of Electrical Engineering, Technion
[3] Rambam Health Care Campus,Department of Epidemiology, Biostatistics and Community Health Sciences, Faculty of Health Sciences
[4] Ben Gurion University of the Negev Beer-Sheva,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Non-invasive oxygen saturation (SpO2) is a central vital sign used to shape the management of COVID-19 patients. Yet, there have been no report quantitatively describing SpO2 dynamics and patterns in COVID-19 patients using continuous SpO2 recordings. We performed a retrospective observational analysis of the clinical information and 27 K hours of continuous SpO2 high-resolution (1 Hz) recordings of 367 critical and non-critical COVID-19 patients hospitalised at the Rambam Health Care Campus, Haifa, Israel. An absolute SpO2 threshold of 93% most efficiently discriminated between critical and non-critical patients, regardless of oxygen support. Oximetry-derived digital biomarker (OBMs) computed per 1 h monitoring window showed significant differences between groups, notably the cumulative time below 93% SpO2 (CT93). Patients with CT93 above 60% during the first hour of monitoring, were more likely to require oxygen support. Mechanical ventilation exhibited a strong effect on SpO2 dynamics by significantly reducing the frequency and depth of desaturations. OBMs related to periodicity and hypoxic burden were markedly affected, up to several hours before the initiation of the mechanical ventilation. In summary, OBMs, traditionally used in the field of sleep medicine research, are informative for continuous assessment of disease severity and response to respiratory support of hospitalised COVID-19 patients. In conclusion, OBMs may improve risk stratification and therapy management of critical care patients with respiratory impairment.
引用
收藏
相关论文
共 50 条
  • [31] Clinical characteristics of moderate or severe COVID-19 infection in patients with rheumatic diseases and analysis of risk factors leading to severe disease
    Wang, Wen
    Sun, Xiang
    Fan, Ran
    Xu, Ling-xiao
    Tang, Jian-ping
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (10) : 1951 - 1959
  • [32] Transfusion Support for Moderate and Severe Cases of COVID-19
    Walker, L.
    Wickenheiser, Z.
    [J]. TRANSFUSION, 2023, 63 : 317A - 318A
  • [33] High incidence of venous thrombosis in patients with moderate-to-severe COVID-19
    Kerbikov, Oleg
    Orekhov, Pavel
    Borskaya, Ekaterina
    Nosenko, Natalia
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (03) : 344 - 347
  • [34] Mortality and Survival Factors in Patients with Moderate and Severe Pneumonia Due to COVID-19
    Galindo-Oseguera, Evelyn
    Pinto-Almazan, Rodolfo
    Arellano-Ramirez, Alfredo
    Gasca-Lopez, Gilberto Adrian
    Ocharan-Hernandez, Maria Esther
    Calzada-Mendoza, Claudia C.
    Castillo-Cruz, Juan
    Martinez-Herrera, Erick
    [J]. HEALTHCARE, 2023, 11 (07)
  • [35] Tocilizumab use in patients with moderate to severe COVID-19: A retrospective cohort study
    Chilimuri, Sridhar
    Sun, Haozhe
    Alemam, Ahmed
    Kang, Kyoung-Sil
    Lao, Peter
    Mantri, Nikhitha
    Schiller, Lawrence
    Sharabun, Myroslava
    Shehi, Elona
    Tejada, Jairo
    Yugay, Alla
    Nayudu, Suresh Kumar
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) : 440 - 446
  • [36] High incidence of venous thrombosis in patients with moderate-to-severe COVID-19
    Oleg Kerbikov
    Pavel Orekhov
    Ekaterina Borskaya
    Natalia Nosenko
    [J]. International Journal of Hematology, 2021, 113 : 344 - 347
  • [37] Evaluation of oxidative stress markers in hospitalized patients with moderate and severe COVID-19
    Zendelovska, Dragica
    Atanasovska, Emilija
    Petrushevska, Marija
    Spasovska, Katerina
    Stevanovikj, Milena
    Demiri, Ilir
    Labachevski, Nikola
    [J]. ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2021, 59 (04) : 375 - 383
  • [38] Intravascular volume status in patients with moderate to severe COVID-19: a case series
    Akbari, Hamideh
    Safaei, Arash
    Akhgar, Atousa
    [J]. FRONTIERS IN EMERGENCY MEDICINE, 2024, 8 (03):
  • [39] Clinical characteristics of moderate and severe cases with COVID-19 in Wuhan, China: a retrospective study
    Sheng, Lingshuang
    Wang, Xiong
    Tang, Ning
    Meng, Fankai
    Huang, Liang
    Li, Dengju
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 21 (01) : 35 - 39
  • [40] Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial
    Darazam, Ilad Alavi
    Shokouhi, Shervin
    Mardani, Masoud
    Pourhoseingholi, Mohamad Amin
    Rabiei, Mohammad Mahdi
    Hatami, Firouze
    Shabani, Minoosh
    Moradi, Omid
    Gharehbagh, Farid Javandoust
    Irvani, Seyed Sina Naghibi
    Amirdosara, Mahdi
    Hajiesmaeili, Mohammadreza
    Rezaei, Omidvar
    Khoshkar, Ali
    Lotfollahi, Legha
    Gachkar, Latif
    Dehbsneh, Hadiseh Shabanpour
    Khalili, Negar
    Soleymaninia, Azam
    Kusha, Akram Hoseyni
    Shoushtari, Maryam Taleb
    Torabinavid, Parham
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99